NDC Code(s) : 61786-676-02
Packager : REMEDYREPACK INC.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
Bupropion HydrochlorideBUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
PRINCIPAL DISPLAY PANEL
DRUG: Bupropion Hydrochloride
GENERIC: BUPROPION HYDROCHLORIDE
DOSAGE: TABLET, FILM COATED, EXTENDED RELEASE
ADMINSTRATION: ORAL
NDC: 61786-676-02
COLOR: orange
SHAPE: ROUND
SCORE: No score
SIZE: 6 mm
IMPRINT: 555
PACKAGING: 30 in 1 BOTTLE
ACTIVE INGREDIENT(S):
- BUPROPION HYDROCHLORIDE 200mg in 1
INACTIVE INGREDIENT(S):
- HYPROMELLOSE 2910 (3 MPA.S)
- HYPROMELLOSE 2910 (50 MPA.S)
- POLYETHYLENE GLYCOLS
- HYPROMELLOSE 2910 (6 MPA.S)
- POLYDEXTROSE
- TITANIUM DIOXIDE
- CELLULOSE, MICROCRYSTALLINE
- HYDROXYPROPYL CELLULOSE (TYPE H)
- MAGNESIUM STEARATE
- FD&C YELLOW NO. 6
- SILICON DIOXIDE
- TRIACETIN